Zapping aggression: could a headset tame impulsive outbursts?

NCT ID NCT04732052

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This clinical trial is testing whether a non-invasive brain stimulation technique called transcranial direct current stimulation (tDCS) can reduce impulsivity and aggression in adults with developmental disabilities. The study will involve 60 participants who have a developmental disability and a recent history of aggressive behavior. Half will receive active tDCS, while the other half will receive a sham (placebo) treatment, to see if the brain stimulation can help lower aggressive symptoms and improve behavior.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS), a non-invasive brain stimulation device
What this could lead to
If effective, tDCS could offer a non-drug, non-invasive way to reduce aggressive behavior and impulsivity in adults with developmental disabilities, potentially improving quality of life and reducing the need for restrictive measures.
What could go wrong
This is an early-stage trial with a small number of participants (60), so results may not be conclusive or widely applicable. The treatment may not work for everyone, and there is a risk of side effects, though tDCS is generally considered safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGGRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Providence Care Hospital

    RECRUITING

    Kingston, Ontario, K7L 4X3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.